Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglitol on Daily Plasma Glucose in Type 2 Diabetes Treated With Insulin
NCT00213122Phase 3Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of miglitol in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoint: Daily Plasma Glucose. Status: completed.
02
Drugs
miglitol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00213122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213122.